Coral Springs, FL, United States of America

Irena Ivnitski-Steele

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of New Mexico, University of Kansas. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irena Ivnitski-Steele. Retrieved from https://idiyas.com/inventor/irena-ivnitski-steele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irena Ivnitski-Steele: Innovator in Cancer Treatment

Introduction

Irena Ivnitski-Steele is a notable inventor based in Coral Springs, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. Her innovative work focuses on selective efflux inhibitors that target cancer-associated transporter proteins.

Latest Patents

Ivnitski-Steele holds a patent for "Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment." This invention provides pyrazolo[1,5-a]pyrimidine compounds that inhibit cancer-associated transporter proteins. The methods described in her patent aim to treat or prevent diseases mediated by these proteins. Notably, her compounds are selective toward ABCG2 over ABCB1, making them particularly effective against drug-resistant and multiple drug-resistant cancers.

Career Highlights

Throughout her career, Irena Ivnitski-Steele has worked with esteemed institutions such as Stc.unm and the University of Kansas Medical Center Research Institute. Her research has contributed to advancements in cancer treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Ivnitski-Steele has collaborated with notable colleagues, including Richard Smith Larson and Larry A Sklar. These partnerships have furthered her research and development efforts in the pharmaceutical field.

Conclusion

Irena Ivnitski-Steele's innovative work in cancer treatment through selective efflux inhibitors highlights her significant impact on the pharmaceutical industry. Her contributions continue to pave the way for advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…